Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 3Omgene Life Sciences Pvt. Ltd
02 4Naprod Life Sciences
03 2Ascent Innovative Medicines
04 5Avet Pharmaceuticals
05 5Bioindustria L.I.M. Spa
06 3Biological E
07 1CHIESI USA INC
08 4Campus Pharma AB
09 6Chemi SpA
10 1Farmak JSC
11 2Flagship Biotech International Pvt. Ltd
12 6Fresenius Kabi AB Brunna
13 5Fresenius Kabi USA
14 4GLAND PHARMA LIMITED
15 3GP Pharm
16 12Generic Health
17 1Hainan Shuangcheng Pharmaceuticals
18 12Hospira, Inc.
19 7Italfarmaco S.p.A
20 3LIFEPHARMA SpA
21 4Labatec Pharm
22 3Lifepharma
23 5Meitheal Pharmaceuticals
24 3Mepha Pharma
25 2Montage Laboratories
26 1NordicInfu Care AB
27 3Northern Medical Group ApS
28 42Novartis Pharmaceuticals Corporation
29 2ORIFARM GROUP AS
30 4Omega Laboratories Limited
31 3Pluviaendo
32 5Sagent Pharmaceuticals
33 33Sun Pharmaceutical Industries Limited
34 12Teva Pharma Australia
35 8Teva Pharmaceutical Industries
36 1Varian Pharmed
37 3Viatris
38 5West-ward Pharmaceutical Corp
39 5Wockhardt
40 7Blank
01 1Ampoule
02 1CAPSULE, DELAYED RELEASE;ORAL
03 3Dry Sub
04 2INF
05 6INJ
06 59INJECTABLE;INJECTION
07 7Inj L?s
08 1Injectable
09 1Injectable Solution
10 3Injectable Suspension
11 6Injection
12 11Injection fluid, resolution
13 2Liquid Injection
14 4Lyophilised Injection
15 1Octreotide 0.05Mg 10 Units Parenteral Use
16 1Octreotide 0.1Mg 10 Units Parenteral Use
17 1Octreotide 0.5Mg 10 Units Parenteral Use
18 1Octreotide 0.5Mg 3 Units' Parenteral Use
19 5Octreotide 100Mcg 5 Units Parenteral Use
20 1Octreotide 10Mg 1 Unit Parenteral Use
21 4Octreotide 1Mg 1 Unit Parenteral Use
22 1Octreotide 20Mg 1 Unit Parenteral Use
23 1Octreotide 30Mg 1 Unit Parenteral Use
24 4Octreotide 500Mcg 5 Units Parenteral Use
25 5Octreotide 50Mcg 5 Units Parenteral Use
26 4POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
27 6POWDER FOR SUSPENSION, SUSTAINED-RELEASE
28 1Powder and liquid to the injection fluid, suspension
29 2Pre-Filled Syringe
30 5SOLUTION
31 19SOLUTION FOR INJECTION
32 1SOLUTION;SUBCUTANEOUS
33 8Solution For Injection
34 5Solution For Injection In Pre-Filled
35 1Solution For Injection In Pre-Filled Syringe
36 1Solution For Injection Or Concentrate For Solution For Infusion
37 1Solution for Injection
38 3Trockensub
39 3Vial
40 18injection
41 30Blank
01 18DISCN
02 4Generic
03 6Originator
04 11Prescription
05 43RX
06 158Blank
01 1BYNFEZIA PEN
02 4Longastatina
03 3Longastatina Lar
04 1MYCAPSSA
05 36OCTREOTIDE ACETATE
06 12OCTREOTIDE ACETATE (PRESERVATIVE FREE)
07 4OCTREOTIDE ACETATE OMEGA
08 3OCTREOTIDE ACETATE PRESERVATIVE FREE
09 1OCTREOTIDE BIOINDUSTRY LIM
10 3OCTREOTIDE FOR INJECTABLE SUSPENSION
11 4OCTREOTIDE SUN
12 1OCTREOTIDE TEVA 20
13 1OCTREOTIDE TEVA 30
14 1Octra
15 4Octreotid Labatec
16 3Octreotid-Mepha LA
17 18Octreotide
18 6Octreotide (SUN)
19 6Octreotide Acetate Omega (Canada)
20 3Octreotide CSC
21 4Octreotide Campus
22 12Octreotide Depot
23 3Octreotide Fresenius Kabi
24 6Octreotide GH
25 1Octreotide Gp Pharm 200Mcg/Ml 1 Vial 5Ml Solution For Injection Efg
26 1Octreotide Gp-Pharm 0.05Mg/Ml 5 Blisters 1Ml Sol Pb And Drip Efg
27 1Octreotide Gp-Pharm 0.1Mg/Ml 5 Blisters 1Ml Soluc Pb And Drip Efg
28 4Octreotide Hospira
29 1Octreotide Hospira 50Mcg/Ml 5 Vial 1Ml Sol Inj Efg
30 3Octreotide Kabi
31 4Octreotide SUN
32 1Octroflex
33 4Oktreotid SUN
34 6SANDOSTATIN
35 6SANDOSTATIN LAR
36 3SIROCTID
37 5Sandostatin
38 1Sandostatin 1Mg/5Ml Injection
39 2Sandostatin 0.05
40 2Sandostatin 0.1
41 2Sandostatin 0.5
42 1Sandostatin 1000Mcg/5Ml 1 Vial 5Ml Solution For Injection And Infusion
43 1Sandostatin 100Mcg/Ml 5 Blisters 1Ml Solution For Injection And Infusion
44 1Sandostatin 50Mcg/Ml 5 Blisters 1Ml Solution For Injection And Infusion
45 1Sandostatin ALLOWS
46 19Sandostatin LAR
47 1Sandostatin Lar 10Mg
48 1Sandostatin Lar 20Mg
49 1Sandostatin Lar 30Mg
50 3Siroctid
51 3TREOJECT
52 3Treoject
53 18Blank
01 48Australia
02 11Canada
03 16India
04 1Iran
05 36Italy
06 12Norway
07 8South Africa
08 7Spain
09 23Sweden
10 13Switzerland
11 3Turkey
12 61USA
13 1Ukraine
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injectable Suspension
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 50MCG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injectable Suspension
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injectable Suspension
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 100MCG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 200MCG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 500MCG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : OCTREOTIDE ACETATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.05MG BASE/ML
Packaging :
Approval Date : 2005-10-03
Application Number : 75957
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OCTREOTIDE ACETATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.1MG BASE/ML
Packaging :
Approval Date : 2005-10-03
Application Number : 75957
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OCTREOTIDE ACETATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Packaging :
Approval Date : 2005-10-03
Application Number : 75957
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OCTREOTIDE ACETATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML
Packaging :
Approval Date : 2005-11-21
Application Number : 75959
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OCTREOTIDE ACETATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML
Packaging :
Approval Date : 2005-11-21
Application Number : 75959
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.05MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.1MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 10MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
